Birgi Mefar

Executive Summary

Birgi Mefar, founded in 1978 and headquartered in Istanbul, is a Turkish medical device manufacturer specializing in sterile, single-use injectable drug delivery systems. The company's product portfolio includes disposable syringes, infusion sets, and other critical components for the pharmaceutical and healthcare sectors. With over four decades of experience, Birgi Mefar has established a strong foothold in the European medical device market, leveraging its manufacturing capabilities and quality standards. The company operates as a private entity, focusing on cost-effective production while maintaining compliance with international regulatory requirements. As the demand for injectable drug delivery systems grows alongside the expansion of biologics and biosimilars, Birgi Mefar is well-positioned to serve both regional and global customers. However, limited public information and the absence of recent financial or operational disclosures constrain a comprehensive assessment of its current performance and growth trajectory.

Upcoming Catalysts (preview)

• Q3 2026CE Mark Renewal Under EU MDR60% success
• TBDExpansion of Prefilled Syringe Production Capacity40% success
• TBDStrategic Partnership for Biosimilar Drug Delivery25% success